Stocks · Health care · Pharmaceutical Preparations

Mirum Pharmaceuticals, Inc.

MIRM Clue Score61
United States Fiscal year ends December CIK 0001759425 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jolanda Howe
16 Oct 2026
SVP, Global Controller
Exercised, kept
16,112
$19.24
$309.99K
Christopher Peetz
6 Oct 2026
Chief Executive Officer
Exercised, kept
6,892
$15.87
$109.38K
Christopher Peetz
6 Oct 2026
Chief Executive Officer
Exercised, kept
5,305
$19.19
$101.80K
Eric Bjerkholt
9 Jun 2026
Chief Financial Officer
Exercised, kept
2,393
$26.49
$63.39K
Peter Radovich
5 Jun 2026
President and COO
Exercised, kept
16,988
$19.19
$326.00K
Peter Radovich
6 Mar 2026
President and COO
Exercised, kept
5,912
$15.87
$93.82K
Christopher Peetz
18 Nov 2025
Chief Executive Officer
Exercised, kept
19,133
$19.24
$368.12K

What was left out

Form 4 filings counted 67
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 28
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 816,731
History held since 18 Jul 2019